VEGFA and breast carcinoma: reported that in ER‐positive breast cancer cells, calycosin inhibits migration and invasion of breast cancer cells with a dose of 150 μM via downregulation of Rab27B (member of the RAS oncogene family), VEGF (vascular endothelial growth factor), and β‐catenin allude anti‐cancer activity of calycosin.65